Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Immunocore Holdings (IMCR) Leases (2022 - 2025)

Immunocore Holdings' Leases history spans 4 years, with the latest figure at $38.8 million for Q4 2025.

  • For Q4 2025, Leases rose 3.03% year-over-year to $38.8 million; the TTM value through Dec 2025 reached $38.8 million, up 3.03%, while the annual FY2025 figure was $38.8 million, 3.03% up from the prior year.
  • Leases for Q4 2025 was $38.8 million at Immunocore Holdings, down from $39.4 million in the prior quarter.
  • Across five years, Leases topped out at $39.7 million in Q3 2024 and bottomed at $30.9 million in Q4 2022.
  • The 4-year median for Leases is $37.9 million (2024), against an average of $36.3 million.
  • The largest YoY upside for Leases was 21.56% in 2025 against a maximum downside of 0.69% in 2025.
  • A 4-year view of Leases shows it stood at $30.9 million in 2022, then grew by 8.32% to $33.5 million in 2023, then increased by 12.3% to $37.6 million in 2024, then increased by 3.03% to $38.8 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Leases are $38.8 million (Q4 2025), $39.4 million (Q3 2025), and $39.4 million (Q2 2025).